What's breaking now, across thousands of outlets.
→ Al Sandrock is calling it quits as CEO of Voyager Therapeutics in the first quarter next year, but he will stay on the board. Chief business and operating officer Robin Swartz, a Sanofi Genzyme ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Star Therapeutics has collected $200 million to see whether its homegrown research can produce a new pipeline of medicines after prior successes that have been shipped elsewhere.
A kind attitude toward oneself and practicing mindfulness can improve functioning in individuals who experience severe premenstrual symptoms, according to a study by psychologists from SWPS University…
The ICMR-funded project will compare blood samples from early-stage patients with those from healthy women
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68%…
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68%…
RIYADH, Saudi Arabia, Oct. 23, 2026 (GLOBE NEWSWIRE) — What began with a single cardiac catheterization laboratory four decades ago has evolved into an advanced cardiovascular program at King Faisal…
